AMPK maintains energy homeostasis and survival in cancer cells via regulating p38/PGC-1α-mediated mitochondrial biogenesis

por Chaube, B, Malvi, P, Singh, S V, Mohammad, N, Viollet, B, Bhat, M K
Publicado 2015

Mice lacking AMP-activated protein kinase α1 catalytic subunit have increased bone remodelling and modified skeletal responses to hormonal challenges induced by ovariectomy and int...

por Jeyabalan, J, Shah, M, Viollet, B, Roux, J P, Chavassieux, P, Korbonits, M, Chenu, C
Publicado 2012

Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status

por Stephenne, X., Foretz, M., Taleux, N., van der Zon, G. C., Sokal, E., Hue, L., Viollet, B., Guigas, B.
Publicado 2011

The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing

por Jeyabalan, J., Viollet, B., Smitham, P., Ellis, S. A., Zaman, G., Bardin, C., Goodship, A., Roux, J. P., Pierre, M., Chenu, C.
Publicado 2013

Corrigendum to “Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms” [Mol. Cell. Endocrinol. 440 15 January...

por Chen, S.C., Brooks, R., Houskeeper, J., Bremner, S.K., Dunlop, J., Viollet, B., Logan, P.J., Salt, I.P., Ahmed, S.F., Yarwood, S.J.
Publicado 2017

AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B

por Johanns, M., Lai, Y.-C., Hsu, M.-F., Jacobs, R., Vertommen, D., Van Sande, J., Dumont, J. E., Woods, A., Carling, D., Hue, L., Viollet, B., Foretz, M, Rider, M H
Publicado 2016

AMP-activated protein kinase α1 protects against diet-induced insulin resistance and obesity. Diabetes 2012;61:3114–3125

por Zhang, W, Zhang, X, Wang, H, Guo, X, Li, H, Wang, Y, Xu, X, Tan, L, Mashek, MT, Zhang, C, Chen, Y, Mashek, DG, Foretz, M, Zhu, C, Zhou, H, Liu, X, Viollet, B, Wu, C, Huo, Y
Publicado 2013